These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 27132583)

  • 1. Management of Hypogonadism in Cardiovascular Patients: What Are the Implications of Testosterone Therapy on Cardiovascular Morbidity?
    Tanna MS; Schwartzbard A; Berger JS; Underberg J; Gianos E; Weintraub HS
    Urol Clin North Am; 2016 May; 43(2):247-60. PubMed ID: 27132583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of testosterone therapy in cardiovascular mortality: culprit or innocent bystander?
    Tanna MS; Schwartzbard A; Berger JS; Alukal J; Weintraub H
    Curr Atheroscler Rep; 2015 Mar; 17(3):490. PubMed ID: 25687258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypogonadism and Testosterone Therapy: Associations With Cardiovascular Risk.
    Maganty A; Osterberg EC; Ramasamy R
    Am J Mens Health; 2015 Jul; 9(4):340-4. PubMed ID: 24972716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dark side of testosterone deficiency: III. Cardiovascular disease.
    Traish AM; Saad F; Feeley RJ; Guay A
    J Androl; 2009; 30(5):477-94. PubMed ID: 19342698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return?
    Traish A
    Investig Clin Urol; 2016 Nov; 57(6):384-400. PubMed ID: 27847912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone administration in older men.
    Matsumoto AM
    Endocrinol Metab Clin North Am; 2013 Jun; 42(2):271-86. PubMed ID: 23702401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Testosterone substitution in patients with hypogonadism].
    Martínez Portillo FJ; Cueva Martínez A; Martin Braun P; Fernández Arancibia MI; Jünemann KP; Alken P
    Arch Esp Urol; 2002 Sep; 55(7):827-38. PubMed ID: 12380312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone deficiency and replacement.
    Howell S; Shalet S
    Horm Res; 2001; 56 Suppl 1():86-92. PubMed ID: 11786693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone deficiency syndrome: benefits, risks, and realities associated with testosterone replacement therapy.
    Hassan J; Barkin J
    Can J Urol; 2016 Feb; 23(Suppl 1):20-30. PubMed ID: 26924592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone replacement therapy: who to evaluate, what to use, how to follow, and who is at risk?
    Afiadata A; Ellsworth P
    Hosp Pract (1995); 2014 Dec; 42(5):69-82. PubMed ID: 25485919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Androgens and cardiovascular risk: A series of case report in the French and Canadian pharmacovigilance databases].
    Rochoy M; Thomas R; Béné J; Deleplanque D; Vantyghem MC; Gautier S; Deplanque D;
    Prog Urol; 2018 May; 28(6):315-321. PubMed ID: 29650456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State-of-the-Art: a Review of Cardiovascular Effects of Testosterone Replacement Therapy in Adult Males.
    Elsherbiny A; Tricomi M; Bhatt D; Dandapantula HK
    Curr Cardiol Rep; 2017 Apr; 19(4):35. PubMed ID: 28361372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late-life onset hypogonadism: a review.
    Bassil N; Morley JE
    Clin Geriatr Med; 2010 May; 26(2):197-222. PubMed ID: 20497841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exogenous testosterone, cardiovascular events, and cardiovascular risk factors in elderly men: a review of trial data.
    Carson CC; Rosano G
    J Sex Med; 2012 Jan; 9(1):54-67. PubMed ID: 21676183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular benefits and risks of testosterone replacement therapy in older men with low testosterone.
    Chrysant SG; Chrysant GS
    Hosp Pract (1995); 2018 Apr; 46(2):47-55. PubMed ID: 29478348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of testosterone replacement on whole body glucose utilisation and other cardiovascular risk factors in males with idiopathic hypogonadotrophic hypogonadism.
    Tripathy D; Shah P; Lakshmy R; Reddy KS
    Horm Metab Res; 1998 Oct; 30(10):642-5. PubMed ID: 9851674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypogonadism: Therapeutic Risks, Benefits, and Outcomes.
    Sigalos JT; Pastuszak AW; Khera M
    Med Clin North Am; 2018 Mar; 102(2):361-372. PubMed ID: 29406064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correction of androgen deficiency in elderly patients].
    Morgunov LIu
    Klin Med (Mosk); 2007; 85(9):17-22. PubMed ID: 18038561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and treatment of hypogonadism in men.
    Bhasin S; Basaria S
    Best Pract Res Clin Endocrinol Metab; 2011 Apr; 25(2):251-70. PubMed ID: 21397197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrinology Update: Testicular Hypogonadism.
    Heidelbaugh JJ
    FP Essent; 2016 Dec; 451():31-41. PubMed ID: 27936533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.